AXKO-0046

N/A

Report date: 2023/05/12 17:26:01
NME

Base Information

Drug NameAXKO-0046
Drug Alias NameAXKO-0046
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionL-lactate dehydrogenase B chain inhibitors
TargetsL-lactate dehydrogenase B chain
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxcelead Drug Discovery Partners Inc
China Registration ClassN/A

Develop Information

Active CompaniesAxcelead Drug Discovery Partners Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A